RegMed is pleased to announce the workshop on “Regenerative Medicine IP & Regulation” organized as part of the 3rdBelgian Symposium on Tissue Engineering (BSTE) on March 20, 2015. The symposium will be hosted at the "Thermotechnisch Instituut" at the Arenberg Castle Park of the University of Leuven.
12h00 - 13h30: Networking lunch and registration
13h30 - 13h45: Welcome and Introduction to the RegMed Platform (Dr. Jan Schrooten)
Part I – Patenting strategies, chaired by Dr. Liesbet Paemen
13h45 – 14h15: "Opportunities and Challenges of an appropriate IP strategy for Cell Therapy" (Dr. Andrej Michalík and Dr. Liesbet Paemen, De Clercq & Partners)
14h15 – 14h45: "Value of IP to defend position in rare diseases & cell therapies: the example of Promethera Biosciences" (Dr. Luca Falciola, Promethera)
14h45 – 15h10: Panel discussion and questions
15h10 – 15h30: Coffee break
Part II – Regulatory challenges, chaired by Dr. Isabelle Huys
15h30 – 15h45: Introduction (Dr. Isabelle Huys, KU Leuven)
15h45 – 16h15: "Recent update on the regulatory framework of Advanced Therapy Medicinal Products (ATMPs)" (Dr. Christiane Niederlander, MHRA)
16h15 – 16h45: "Advanced Therapy Medicinal Products in the context of hospitals" (Dr. Gilbert Verbeken, Queen Astrid Military Hospital)
16h45 – 17h15: Panel discussion and questions
Friday March 20th, 2015
Thermotechnisch Instituut
Kasteelpark Arenberg 41
3001 Heverlee (BE)
Further practical information on this 2-day BSTE Symposium is available at https://www.mtm.kuleuven.be/prometheus/BSTE/
The registration fee for the workshop is €40, including lunch. If you wish to join, please register through the following link:https://www.mtm.kuleuven.be/prometheus/BSTE/Registration.
We look forward to seeing you at the occasion!